Kuros Biosciences' MagenetOs Flex Matrix was cleared by the FDA for use as a bone void filler in the posterolateral spine.
MagnetOs Flex is an open matrix bone graft designed for more predictable spinal fusions, according to an April 21 news release. It has a fibrillar and flexible structure that optimizes the company's pro-healing NeedleGrip surface technology.
This is the third FDA clearance for Kuros' MagnetOs product family in the last seven months.